- Practice your ENZN trading strategies and win cash in our stock game.
NEW YORK ( TheStreet) -- Enzon Pharmaceuticals (Nasdaq: ENZN) hit a new 52-week low Friday as it is currently trading at $7.19, below its previous 52-week low of $7.20 with 102,690 shares traded as of 3:25 p.m. ET. Average volume has been 366,100 shares over the past 30 days. Enzon has a market cap of $352.5 million and is part of the health care sector and drugs industry. Shares are down 39% year to date as of the close of trading on Thursday. Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs.